Previous 10 | Next 10 |
home / stock / crsp / crsp articles
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgr...
Crispr Therapeutics (NASDAQ:CRSP) shares are trading higher Thursday after Wolfe Research analyst Andy Chen initiated coverage on Crispr Therapeuti...
U.S. stocks were mostly higher, with the Dow Jones index gaining more than 150 points on Wednesday. Shares of Reliance Steel & Aluminum Co. (N...
CRISPR Therapeutics (NASDAQ:CRSP) has outperformed the market over the past 5 years by 4.96% on an annualized basis producing an average annual ret...
CRISPR Therapeutics (NASDAQ:CRSP) has outperformed the market over the past 5 years by 1.56% on an annualized basis producing an average annual ret...
On Wednesday, Cathie Wood-led Ark Invest made a significant move by selling a substantial portion of its stake in DraftKings Inc (NASDAQ:DKNG). T...
Tuesday, the FDA approved CRISPR Therapeutics AG’s (NASDAQ:CRSP)/Vertex Pharmaceutical Incorporated’s (NASDAQ:VRTX) Casg...
On Tuesday, Cathie Wood-led Ark Invest made a significant move by selling $15.84 million worth of ProShares Bitcoin Strategy ETF (NYSE:BITO) units....
ZUG, Switzerland and BOSTON, Jan. 03, 2024 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (NASDAQ:CRSP), a biopharmaceutical company focused on creatin...
News, Short Squeeze, Breakout and More Instantly...
CRISPR Therapeutics AG Company Name:
CRSP Stock Symbol:
NASDAQ Market:
CRISPR Therapeutics AG Website:
2024-06-20 17:56:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...